We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Systematic Nursing Orientations in the Reduction of Predicted Cardiovascular Risk in Patients With Coronary Artery Disease. (NERE-CR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00795626
Recruitment Status : Completed
First Posted : November 21, 2008
Last Update Posted : February 5, 2013
Sponsor:
Information provided by (Responsible Party):
Eneida Rejane Rabelo da Silva, Hospital de Clinicas de Porto Alegre

Brief Summary:
Evaluate the impact of systematic nursing orientations in the reduction of predicted cardiovascular risk in patients with coronary artery disease during four nursing visits for a 1-year period and compare to a group of patients submitted to conventional treatment.

Condition or disease Intervention/treatment
Coronary Heart Disease Behavioral: Systematic education in the reduction of the risk estimate to cardiovascular events

Detailed Description:
Assess 184 (two groups) patients during four nursing visits for a 1-year period and compare to a group of patients submitted to conventional treatment. We will evaluate the impact of systematic nursing orientations in the reduction of predicted cardiovascular risk in patients with coronary artery disease.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 74 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Impact of Systematic Nursing Orientations in the Reduction of Predicted Cardiovascular Risk in Patients With Coronary Artery Disease.
Study Start Date : January 2007
Primary Completion Date : May 2011
Study Completion Date : July 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: Lifestyle counseling

Two groups:

  • control - conventional care
  • intervention - systematic education in the reduction of the risk estimate to cardiovascular events
Behavioral: Systematic education in the reduction of the risk estimate to cardiovascular events
Systematic education during 4 assessment throughout one year



Primary Outcome Measures :
  1. Reduction of Predicted Cardiovascular Risk [ Time Frame: one year ]

Secondary Outcome Measures :
  1. Knowledge of the risk factors and the adhesion to pharmacology treatment; Reduction of the modified risk factors in the previous knowledge of patients and their adhesion; [ Time Frame: one year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients of both sexes;
  • aged 18 years or older;
  • diagnosed with ACS (unstable angina and acute myocardial infarction with ST segment elevation and without ST segment elevation) with CAD diagnosed by cardiac catheterization or electrocardiogram;
  • patients have to agree to participate by signing a consent term

Exclusion Criteria:

  • patients with cognitive deficits;
  • neurological sequelae;
  • who are not able to come for visits, or who do not consent to participate in the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00795626


Locations
Brazil
Eneida Rejane Rabelo
Porto Alegre, Rio Grande do Sul, Brazil, 90035003
Sponsors and Collaborators
Hospital de Clinicas de Porto Alegre
Investigators
Principal Investigator: Eneida R Rabelo, RN, ScD Federal University of Rio Grande do Sul Post Grad Prog

Responsible Party: Eneida Rejane Rabelo da Silva, Professor, PhD., Hospital de Clinicas de Porto Alegre
ClinicalTrials.gov Identifier: NCT00795626     History of Changes
Other Study ID Numbers: UFRGS and HCPA 06570
First Posted: November 21, 2008    Key Record Dates
Last Update Posted: February 5, 2013
Last Verified: February 2013

Keywords provided by Eneida Rejane Rabelo da Silva, Hospital de Clinicas de Porto Alegre:
nursing education
cardiovascular risk factors
coronary heart disease

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases